Francis P. Worden - Publications, H-index & Citations

Francis P. Worden

university of michigan

64H指数

549论文数

2.2W被引数

收录论文 129

发表时间

MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial MDM2抑制剂Alrizomadlin（APG-115）在TP53野生型唾液腺癌中的I期临床试验

Nature Communications

IF15.7

2026-03-19

OAAI

Alexander T. Pearson; Jameel Muzaffar; Kedar Kirtane; Emily Bellile; Krithika Suresh; Ari J. Rosenberg; Francis Worden; Christine H. Chung; Everett Vokes; J. Chad Brenner; Apurva Bhangale; Jon McHugh; Kristy Warner; Felipe Nor; Jacques E. Nor; Keri Innes; Yifan Zhai; Tommy Fu; Paul L. Swiecicki

Review of the Management of Periocular Cutaneous Squamous Cell Carcinoma With Perineural Spread Over the Last Decade 过去十年眼睑周围皮肤鳞状细胞癌伴神经周围扩散的管理综述

Ophthalmic Plastic and Reconstructive Surgery

IF1.3

2026-01-01

PREAI

Juntipwong, Sarinee; Alizada, Mehriban; Simmon, Kirsten; Sarigul Sezenoz, Almila; Elner, Victor M.; Kim, Denise S.; Nelson, Christine C.; Hayman, James Alan; Swiecicki, Paul Loren; Worden, Francis Paul; Demirci, Hakan

Prevalence and clinical characteristics of Lynch syndrome-associated adrenocortical carcinoma 林奇综合征相关肾上腺皮质癌的患病率及临床特征

Endocrine-Related Cancer

IF4.6

2026-01-01

PREAI

Sinha, Avilasha; Wolf, Katherine, I; Osborne, Jenae; Hesseltine, Elizabeth A.; Worden, Francis P.; Giordano, Thomas J.; Hammer, Gary D.; Else, Tobias

Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx 中性粒细胞与淋巴细胞比值及淋巴细胞与单核细胞比值可预测局部晚期喉鳞状细胞癌患者诱导化疗后的生存改善和疗效反应。

Head and Neck-Journal for the Sciences and Specialties of the Head and Neck

IF2.2

2025-12-01

OAAI

Risch, Zachary; Bellile, Emily; Bughrara, Moneb S.; Swiecicki, Paul L.; Casper, Keith; Malloy, Kelly; Hogikyan, Norman; Spector, Matthew; Shuman, Andrew; Stucken, Chaz; Chinn, Steven; Chepeha, Douglas C.; Jolly, Shruti; Mierzwa, Michelle; Bradford, Carol; Eisbruch, Avraham; Carey, Thomas; Prince, Mark; Wolf, Gregory T.; Worden, Francis P.

Tumor Hypoxia and CD8+ T-Cell Infiltration in Patients With Advanced Laryngeal Cancer 肿瘤缺氧和CD8+ T细胞浸润在晚期喉癌患者中的研究

jama otolaryngology head neck surgery

IF2.5

2025-05-05

OAAI

Joshua D. Smith MD; Elizabeth Gensterblum-Miller PhD; David W.A. Forner MD, MSc, FRCSC; Pratyusha Yalamanchi MD, MBA; Marisa R. Buchakjian MD, PhD; Steven B. Chinn MD, MS, FACS; Andrew G. Shuman MD; Keith A. Casper MD; Kelly M. Malloy MD; Chaz L. Stucken MD; Scott A. Mclean MD, PhD; Michelle L. Mierzwa; Jennifer Shah; Paul L. Swiecicki MD; Francis P. Worden MD; Mark E.P. Prince MD; Matthew E. Spector MD; J. Chad Brenner PhD; Molly E. Heft Neal MD

Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement 放射性碘难治性不可切除或转移性甲状腺癌的再分化疗法：国际甲状腺肿瘤研究组声明

The Lancet Diabetes & Endocrinology

IF0

2025-04-30

OAAI

Sophie Leboulleux; Laura Boucai; Naifa Busaidy; Cosimo Durante; James A Fagin; Sasan Fazeli; Andrew G Gianoukakis; Bryan R Haugen; Hyunseok Kang; Bhavana Konda; Theodore W Laetsch; Laura Locati; Mabel Ryder; Christine Spitzweg; Francis P Worden; Lori Wirth; Alan Ho

Head and Neck Cancers, Version 2.2025 Featured Updates to the NCCN Guidelines 头颈癌，版本2.2025：NCCN指南特色更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-02-01

PREAI

Colevas, A. Dimitrios; Cmelak, Anthony J.; Pfister, David G.; Spencer, Sharon; Adkins, Douglas; Birkeland, Andrew C.; Brizel, David M.; Busse, Paul M.; Caudell, Jimmy J.; Durm, Greg; Fakhry, Carole; Galloway, Thomas; Geiger, Jessica L.; Gillison, Maura L.; Glastonbury, Christine; Haddad, Robert I.; Hicks Jr, Wesley L.; Hitchcock, Ying J.; Jimeno, Antonio; Juloori, Aditya; Kase, Michael; Leizman, Debra; Maghami, Ellie; Mell, Loren K.; Mittal, Bharat B.; Pinto, Harlan A.; Price, Katharine; Rocco, James W.; Rodriguez, Cristina P.; Schwartz, David; Shah, Jatin P.; Sher, David; St John, Maie; Wang, He; Weinstein, Gregory; Worden, Francis; Bruce, Justine Yang; Yom, Sue S.; Zhen, Weining; Montgomery, Sarah; Darlow, Susan D.

Squamoid Eccrine Ductal Carcinoma Displays Ultraviolet Mutations and Intermediate Gene Expression Relative to Squamous Cell Carcinoma, Microcystic Adnexal Carcinoma, and Porocarcinoma

MODERN PATHOLOGY

IF5.5

2024-11-01

PREAI

Harms, Paul W.; Runge, Mason; Chan, May P.; Liu, Chia-Jen; Qin, Zhaoping; Worden, Francis; Robinson, Dan R.; Chinnaiyan, Arul M.; Mclean, Scott A.; Harms, Kelly L.; Fullen, Douglas R.; Patel, Rajiv M.; Andea, Aleodor A.; Udager, Aaron M.

First-in-human, phase 1 study of a selective RET inhibitor, LOXO-260, in patients with RET inhibitor refractory, RET-altered cancers

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Subbiah, V.; Drilon, A.; Bestvina, C.; Garon, E. B.; Wirth, L.; Worden, F.; Piha-Paul, S.; Rotow, J.; Johnson, M.; Kang, H.; Dong, S. M.; Weiss, J.; Pennell, N. A.; Sukrithan, V.; Lombard, A.; Szpurka, A. M.; Li, J.; Manvelyan, M.; Avsar, E.; Brose, M. S.

Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer

ORAL ONCOLOGY

IF3.9

2024-09-01

PREAI

Benjamin, William J.; Feng, Allen L.; Neal, Molly Heft; Bellile, Emily; Casper, Keith A.; Malloy, Kelly M.; Rosko, Andrew J.; Stucken, Chaz L.; Prince, Mark E.; Mierzwa, Michelle L.; Taylor, Jeremy M. G.; Eisbruch, Avraham; Spector, Matthew E.; Wolf, Gregory T.; Swiecicki, Paul L.; Worden, Francis P.; Chinn, Steven B.

Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study

THYROID

IF6.7

2024-07-01

PREAI

Chen, Debbie W.; Carr, Grant; Worden, Francis P.; Veenstra, Christine M.; Haymart, Megan R.; Banerjee, Mousumi

A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2024-06-29

OAAI

Sehgal, Kartik; Serritella, Anthony; Liu, Mofei; Oneill, Anne; Nangia, Chaitali; Pappa, Theodora; Demeure, Michael J.; Worden, Francis P.; Haddad, Robert I.; Lorch, Jochen

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers

CLINICAL CANCER RESEARCH

IF10.2

2024-06-26

PREAI

French, Jena D.; Haugen, Bryan R.; Worden, Francis P.; Bowles, Daniel W.; Gianoukakis, Andrew G.; Konda, Bhavana; Dadu, Ramona; Sherman, Eric J.; McCue, Shaylene; Foster, Nathan R.; Nikiforov, Yuri E.; Farias, Ticiana D. J.; Norman, Paul J.; Wirth, Lori J.

Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy 凡德他尼在放射性碘治疗无效的局部晚期或转移性分化型甲状腺癌中的应用

ENDOCRINE-RELATED CANCER

IF4.6

2024-06-03

OAAI

Brose, Marcia S.; Capdevila, Jaume; Elisei, Rossella; Bastholt, Lars; Fuehrer-Sakel, Dagmar; Leboulleux, Sophie; Sugitani, Iwao; Taylor, Matthew H.; Wang, Zhuoying; Wirth, Lori J.; Worden, Francis P.; Bernard, John; Caferra, Paolo; Colzani, Raffaella M.; Liu, Shiguang; Schlumberger, Martin

Enhancing precision: A predictive model for 177 Lu- DOTATATE treatment response in neuroendocrine tumors using quantitative 68 Ga-DOTATATE PET and clinicopathological biomarkers

THERANOSTICS

IF13.3

2024-01-01

OAAI

Akhavanallaf, Azadeh; Joshi, Sonal; Mohan, Arathi; Worden, Francis P.; Krauss, John C.; Zaidi, Habib; Frey, Kirk; Suresh, Krithika; Dewaraja, Yuni K.; Wong, Ka Kit

Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States

ENDOCRINE

IF2.9

2023-12-16

OAAI

Worden, Francis; Rajkovic-Hooley, Olivera; Reynolds, Neil; Milligan, Gary; Zhang, Jingchuan

Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer

EUROPEAN THYROID JOURNAL

IF4.3

2023-12-14

OAAI

Gianoukakis, Andrew G.; Choe, Jennifer H.; Bowles, Daniel W.; Brose, Marcia S.; Wirth, Lori J.; Owonikoko, Taofeek; Babajanyan, Svetlana; Worden, Francis P.

Real-World Use of Systemic Therapies for the Treatment of Advanced Thyroid Cancers

ENDOCRINE PRACTICE

IF4.6

2023-11-01

PREAI

Chen, Debbie W.; Banerjee, Mousumi; Xu, Tianyi; Worden, Francis P.; Haymart, Megan R.

Updated safety and efficacy of selpercatinib in patients (pts) with RET-activated thyroid cancer: Data from LIBRETTO-001

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Wirth, L. J.; Subbiah, V.; Worden, F. P.; Solomon, B. J.; Robinson, B.; Hadoux, J.; Tomasini, P.; Weiler, D.; Deschler-Baier, B.; Tan, D. S. W.; Lin, Y.; Bayt, T.; Maeda, P.; Drilon, A.; Cassier, P.

Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of 18F-Fluorodeoxyglucose Positron Emission Tomography Response- Based De-escalated Definitive Chemoradiotherapy for p16+Oropharynx Cancer: A Planned Interim Analysis

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2023-09-01

PREAI

Allen, Steven G.; Rosen, Benjamin S.; Aryal, Madhava; Cao, Yue; Schipper, Matthew J.; Wong, Ka Kit; Casper, Keith A.; Chinn, Steven B.; Malloy, Kelly M.; Prince, Mark E.; Rosko, Andrew J.; Shuman, Andrew G.; Spector, Matthew E.; Stucken, Chaz L.; Swiecicki, Paul L.; Worden, Francis P.; Brenner, J. Chad; Schonewolf, Caitlin A.; Elliott, David A.; Mierzwa, Michelle L.; Shah, Jennifer L.

研究方向